These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15505021)

  • 1. Decreasing restenosis following angioplasty: the potential of peroxisome proliferator-activated receptor gamma agonists.
    Fonseca VA; Diez J; McNamara DB
    Diabetes Care; 2004 Nov; 27(11):2764-6. PubMed ID: 15505021
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury.
    Qin HD; Huang D; Weng XD; Xu F
    J Cell Physiol; 2009 Nov; 221(2):387-93. PubMed ID: 19562688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fighting restenosis - never-ending story].
    Przewłocki T
    Kardiol Pol; 2010 Sep; 68(9):994-5. PubMed ID: 20859887
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of postangioplasty restenosis].
    Kitai T; Ishiwata S; Yamaguchi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():627-31. PubMed ID: 12735042
    [No Abstract]   [Full Text] [Related]  

  • 5. Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):799-800. PubMed ID: 17377984
    [No Abstract]   [Full Text] [Related]  

  • 6. In-stent restenosis: 3 novel solutions show promise for heart patients. Stopping regrowth of plaque inside stents is a priority in reducing the need for repeat revascularizations.
    Duke Med Health News; 2007 Mar; 13(3):3-4. PubMed ID: 17385240
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of drug-eluting stent restenosis.
    Ishikawa K; Aoyama Y; Hirayama H
    J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Palmaz-Schatz stent].
    Kobayashi N; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):947-53. PubMed ID: 12436643
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
    Goldschmidt-Clermont PJ
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():1E. PubMed ID: 12668856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Restenosis after coronary angioplasty: pathomechanism and potential targets for therapeutic intervention. Focus on inflammation].
    Koziński M; Sukiennik A; Rychter M; Kubica J; Sinkiewicz W
    Postepy Hig Med Dosw (Online); 2007; 61():58-73. PubMed ID: 17369774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of coronary stent].
    Nobuyoshi M; Kimura T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):934-41. PubMed ID: 12436641
    [No Abstract]   [Full Text] [Related]  

  • 12. Catheter entrapment during balloon angioplasty in patient with in-stent restenosis: an unusual complication and its surgical management.
    Goksin I; Baltalarli A; Semiz E; Gurses E; Sacar M; Ozcan V; Sungurtekin H
    J Card Surg; 2007; 22(2):160-2. PubMed ID: 17338758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coated stents for the prevention of restenosis: Part I.
    Babapulle MN; Eisenberg MJ
    Circulation; 2002 Nov; 106(21):2734-40. PubMed ID: 12438301
    [No Abstract]   [Full Text] [Related]  

  • 14. New technologies in percutaneous coronary interventions: drug-coated balloons.
    Kleber FX; Scheller B; Serruys PW
    EuroIntervention; 2011 May; 7 Suppl K():K7. PubMed ID: 22027732
    [No Abstract]   [Full Text] [Related]  

  • 15. [Self-expanding stent].
    Kadota K; Mitsudo K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):942-6. PubMed ID: 12436642
    [No Abstract]   [Full Text] [Related]  

  • 16. Stenting small vessels? Not a small issue.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):430-1. PubMed ID: 15274149
    [No Abstract]   [Full Text] [Related]  

  • 17. A cagey proposition.
    Ho YD; Lee DP
    J Invasive Cardiol; 2008 Jan; 20(1):28. PubMed ID: 18174615
    [No Abstract]   [Full Text] [Related]  

  • 18. Engineering a bioresorbable stent: REVA programme update.
    Pollman MJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F54-7. PubMed ID: 22100677
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of restenosis with antioxidants: mechanisms and implications.
    Tardif JC; Grégoire J; L'Allier PL
    Am J Cardiovasc Drugs; 2002; 2(5):323-34. PubMed ID: 14727962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.